Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex

被引:118
作者
Bharadwaj, Mandvi [1 ]
Illing, Patricia [1 ]
Theodossis, Alex [2 ]
Purcell, AnthonyW. [3 ]
Rossjohn, Jamie [2 ]
McCluskey, James [1 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[2] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia
[3] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 | 2012年 / 52卷
关键词
adverse drug reactions; T cells; HLA polymorphism; delayed type hypersensitivity; hepatotoxicity; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; T-CELL-RECEPTOR; CHRONIC BERYLLIUM DISEASE; INDUCED LIVER-INJURY; IMMUNE-MEDIATED DESTRUCTION; CUTANEOUS ADVERSE-REACTIONS; ASPIRIN-INTOLERANT ASTHMA; HUMAN CLASS-I; MHC-CLASS-II;
D O I
10.1146/annurev-pharmtox-010611-134701
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human leukocyte antigen (HLA) genes are the most polymorphic in the human genome and are critical in regulating specific immunity, hence their historical discovery as "immune response" genes. HLA allotypes are also implicated in unwanted immune reactions, including drug hypersensitivity syndrome, in which small therapeutic drugs interact with antigenic peptides to drive T cell responses restricted by host HLA. Abacavir, allopurinol, and carbamazepine are three commonly used drugs that cause a T cell-mediated hypersensitivity that is HLA linked, with each drug exhibiting striking specificity for presentation by defined HLA allotypes. Recent findings have begun to unearth the mechanistic basis for these HLA associations, and here we review recent advances in the field of HLA-associated drug hypersensitivities.
引用
收藏
页码:401 / +
页数:37
相关论文
共 168 条
[1]  
Alfirevic A, 2005, BRIT J CLIN PHARMACO, V59, P641
[2]   In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[3]   Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition [J].
Archbold, Julia K. ;
Macdonald, Whitney A. ;
Gras, Stephanie ;
Ely, Lauren K. ;
Miles, John J. ;
Bell, Melissa J. ;
Brennan, Rebekah M. ;
Beddoe, Travis ;
Wilce, Matthew C. J. ;
Clements, Craig S. ;
Purcell, Anthony W. ;
McCluskey, James ;
Burrows, Scott R. ;
Rossjohn, Jamie .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (01) :209-219
[4]   Life-threatening adverse events of antiepileptic drugs [J].
Arroyo, S ;
de la Morena, A .
EPILEPSY RESEARCH, 2001, 47 (1-2) :155-174
[5]   The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B☆41 allotypic family [J].
Bade-Doeding, Christina ;
Theodossis, Alex ;
Gras, Stephanie ;
Kjer-Nielsen, Lars ;
Eiz-Vesper, Britta ;
Seltsam, Axel ;
Huyton, Trevor ;
Rossjohn, Jamie ;
McCluskey, James ;
Blasczyk, Rainer .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01) :110-118
[6]   HLA/KIR Restraint of HIV: Surviving the Fittest [J].
Bashirova, Arman A. ;
Thomas, Rasmi ;
Carrington, Mary .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29, 2011, 29 :295-317
[7]  
BATCHELOR JR, 1980, LANCET, V1, P1107
[8]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[9]  
BRANDER C, 1995, J IMMUNOL, V155, P2670
[10]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39